Bridging the dimensions: multi-parameter optimisation of 2D and 3D SAR

webinar

Tue, 28 Jan 2020, 17:00 CET (Berlin)

Dr. Matthew Segall, CEO at Optibrium Ltd, Cambridge, United Kingdom

Bridging the dimensions: multi-parameter optimisation of 2D and 3D SAR

There has typically been a divide between tools for three-dimensional (3D) structure-based design and those for analysis of structure-activity relationships (SAR) based on two-dimensional (2D) compound structures. Seamless integration between these approaches would enable all the available structural knowledge to be used to guide the efficient design of high quality, active compounds.

We have been working together with BioSolveIT to seamlessly integrate their unique SeeSAR™ technology, including pose generation, HYDE scoring and torsion angle analysis within our StarDrop™ platform. In this webinar, we will illustrate how 2D analyses of SAR, such as activity cliff detection and matched molecular pair analyses, can be seamlessly linked in a highly visual way with related 3D structural information to understand and rationalize this SAR. Furthermore, information from 2D models of key physicochemical and absorption, distribution, metabolism, elimination and toxicity (ADMET) properties can be combined with 3D docked poses and affinity estimates. The influence of each atom or functional group on these properties can be highlighted and combined with visualization of the atomistic contributions to binding affinity, enabling development of optimization strategies that balance potency with the ADMET properties required in a safe and efficacious drug.

These combined capabilities enable the efficient design of compounds with improved target affinity in a truly multi-parameter optimization environment.

Current news

A Milestone with Our Pioneering Partner: REAL Space Crosses 100 Billion
October 14, 2026 13:51 CEST
Crossing the 100 Billion Mark REAL Space has entered the 100+ billion era. The October update brings Enamine’s Chemical Space to 113,699,103,092 virtual product molecules, opening up an even larger collection of make-on-demand chemistry for your drug discovery projects. Built from 211,806 building blocks and 161 chemical reactions, implemented as...
Read on
category
Software
Make It Double! — SeeSAR and HPSee Updates
October 14, 2026 08:00 CEST
The SeeSAR 15.1 and HPSee 2.4 Updates SeeSAR 15.1 ‘Apollo’ and HPSee 2.4 ‘Electra’ are here! The double release brings per-synthon estimates of extension result counts to Chemical Space Docking and new reference-molecule support and automatic best-spot selection to Activity Spotter. Alongside these additions, faster molecule transfers and more flexible...
Read on
Entering The Trillion Era: AMBrosia Update
October 7, 2026 13:24 CEST
More chemistry. Trillions of possibilities. AMBrosia enters its third version with more than 2.4 trillion virtual product molecules. Developed in close collaboration with Ambinter (a brand of Greenpharma), the expanded Chemical Space combines 313,777 building blocks through 54 chemical reactions, implemented as 131 technical reactions, opening up a wealth of...
Read on